Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of ischemic stroke: a meta-analysis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Blood Coagulation and Fibrinolysis

• Publication date

  2007-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MBC.0b013e3281ec4eeePMID 17581326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene with stroke or encephalopathy after cardiac surgery

  2006cited by this paper
• Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.

  2006cited by this paper
• Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Risk of Stroke: Replicated Findings in Two Nested Case–Control Studies Based on Independent Cohorts

  2005cited by this paper
• Fibrinolytic Gene Polymorphism and Ischemic Stroke

  2005cited by this paper
• Molecular Bias

  2005cited by this paper
• Genetic Epidemiology

  2005cited by this paper
• Why Most Published Research Findings Are False

  2005cited by this paper
• Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials.

  2005cited by this paper
• A method for meta‐analysis of molecular association studies

  2005cited by this paper
• The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke

  2004cited by this paper
• Equivocal roles of tissue-type plasminogen activator in stroke-induced injury.

  2004cited by this paper
• Meta-analysis of genetic association studies.

  2004cited by this paper
• Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk

  2004cited by this paper
• Plasminogen Activator Inhibitor-1 4G Allele in the 4G/5G Promoter Polymorphism Increases the Occurrence of Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage

  2004cited by this paper
• Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls.

  2004cited by this paper
• Lack of association of the plasminogen activator inhibitor‐1 4G/5G promoter polymorphism with cardiovascular disease in the elderly

  2003cited by this paper
• 4G/4G Genotype of PAI-1 Gene Is Associated With Reduced Risk of Stroke in Elderly

  2003cited by this paper
• Promoter (4G/5G) Plasminogen Activator Inhibitor-1 Genotype and Plasminogen Activator Inhibitor-1 Levels in Blacks, Hispanics, and Non-Hispanic Whites: The Insulin Resistance Atherosclerosis Study

  2003cited by this paper
• 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke.

  2003cited by this paper
• Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China.

  2003cited by this paper
• Prothrombotic gene polymorphisms and atherothrombotic cerebral infarction

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Determinants of Plasminogen Activator Inhibitor-1 in South Asians with Ischaemic Stroke

  2002cited by this paper
• PAI‐1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs

  2002cited by this paper
• Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations.

  2002cited by this paper
• Cryptogenic Stroke in Relation to Genetic Variation in Clotting Factors and Other Genetic Polymorphisms Among Young Men and Women

  2002cited by this paper
• The Association of PAI-1 Promoter 4G/5G Insertion/Deletion Polymorphism with Myocardial Infarction and Stroke in Young Women

  2002cited by this paper
• Plasminogen activator inhibitor genotype and brain infarction.

  2001cited by this paper
• BMC Medical Research Methodology BioMed Central BMC 22002, Medical Research Methodology

  2001cited by this paper
• Genetic Variation in Coagulation and Fibrinolytic Proteins and Their Relation With Acute Myocardial Infarction: A Systematic Review

  2001cited by this paper
• 4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene and Insertion/Deletion Polymorphism of the Tissue-Type Plasminogen Activator Gene in Atherothrombotic Stroke

  2001cited by this paper
• The plasminogen activator inhibitor (PAI)‐1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children

  2001cited by this paper
• The 4G/4G genotype at nucleotide position −675 in the promotor region of the plasminogen activator inhibitor 1 (PAI‐1) gene is less frequent in young patients with minor stroke than in controls

  2000cited by this paper
• Plasminogen-activator inhibitor type 1 and coronary artery disease.

  2000cited by this paper
• Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women.

  2000cited by this paper
• Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease.

  2000cited by this paper
• Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure

  1999cited by this paper
• Angiotensin I-converting enzyme and plasminogen activator inhibitor-1 gene variants: risk of mortality and fatal cardiovascular disease in an elderly population-based cohort.

  1999cited by this paper
• 4G/5G Promoter PAI-1 Gene Polymorphism Is Associated with Plasmatic PAI-1 Activity in Italians: A Model of Gene-Environment Interaction

  1998cited by this paper
• Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort.

  1998cited by this paper
• Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia.

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Explaining heterogeneity in meta-analysis: a comparison of methods.

  1997cited by this paper
• Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Promoter Polymorphism and Levels in Subjects with Cerebrovascular Disease

  1997cited by this paper
• Structure of plasminogen activator inhibitor 1 (PAI-1) and its function in fibrinolysis: an update

  1995cited by this paper
• Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine

  1994cited by this paper
• Operating characteristics of a rank correlation test for publication bias.

  1994cited by this paper
• The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

  1993cited by this paper
• Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial

  1993cited by this paper
• Cumulative meta-analysis of therapeutic trials for myocardial infarction.

  1992cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• The Elderly

  1984cited by this paper
• An Analysis of Variance Test for Normality (Complete Samples)

  1965cited by this paper

• The Association of Genetic Polymorphisms Of Plasminogen Activator Inhibitor-1 4G/5G And Tissue Plasminogen Activator With Type 2 Diabetes Mellitus Is Influenced By Ethnicity

  2022cites this paper
• Markers of Hereditary Thrombophilia with Unclear Significance

  2022cites this paper
• PAI-1: A Major Player in the Vascular Dysfunction in Obstructive Sleep Apnea?

  2022cites this paper
• Quantile‐specific heritability of plasminogen activator inhibitor type‐1 (PAI‐1, aka SERPINE1) and other hemostatic factors

  2021cites this paper
• Transcriptomic Profiling of Femoral Veins in Deep Vein Thrombosis in a Porcine Model

  2021cites this paper
• Correlation Between PAI-1 Gene 4G/5G Polymorphism and the Risk of Thrombosis in Ph Chromosome-Negative Myeloproliferative Neoplasms

  2020cites this paper
• Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

  2018cites this paper
• SPECIFIC POLYMORPHISM 4 G / 5 G GENE FOR PAI 1 AS A POSSIBLE CAUSE OF CEREBRAL VENOUS THROMBOSIS : A CASE REPORT

  2017cites this paper
• Specific Polymorphism 4G/5G Gene for PAI-1 as a Possible Cause of Cerebral Venous Thrombosis: A Case Report

  2017cites this paper
• Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility

  2016cites this paper
• Is acute stress and plasminogen activator inhibitor polymorphism associated with acute ischemic stroke?

  2016cites this paper
• Polimorfizmi u genima za koagulacijske čimbenike i enzime metabolizma homocisteina u djece s moždanim udarom

  2016cites this paper
• Fibrinolysis and the control of blood coagulation.

  2015cites this paper
• What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers

  2015cites this paper
• The role of hypercoagulability in ischemic colitis

  2015cites this paper
• [Update on the genetics of stroke].

  2014cites this paper
• Residual vein thrombosis and onset of post-thrombotic syndrome: influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene.

  2014cites this paper
• Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Chinese population

  2014influential citation
• Gorlin-Goltz syndrome and stroke: a case report.

  2014cites this paper
• The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis

  2014cites this paper
• Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai children with arterial ischemic stroke.

  2014cites this paper
• infarction and ischaemic stroke in young women : differences , similarities and implications

  2013cites this paper
• Thrombophilic Abnormalities in Patients With or Without Pulmonary Embolism Following Elective Spinal Surgery

  2013cites this paper
• Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis.

  2013cites this paper
• Association between the SERPINE 1 ( PAI-1 ) 4 G / 5 G insertion / deletion promoter polymorphism ( rs 1799889 ) and pre-eclampsia : a systematic review and meta-analysis

  2013cites this paper
• Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype.

  2012cites this paper
• Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case–control study

  2012cites this paper
• Meta-analysis of the plasminogen activator inhibitor-1 (PAI-1) gene with insertion/deletion 4G/5G polymorphism and its susceptibility to ischemic stroke in Thai population

  2012influential citation
• Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects

  2011cites this paper
• Causal Relationship of Susceptibility Genes to Ischemic Stroke: Comparison to Ischemic Heart Disease and Biochemical Determinants

  2010cites this paper
• Advanced age, low left atrial appendage velocity, and Factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation

  2010cites this paper
• Candidate Gene Polymorphisms for Ischemic Stroke

  2009cites this paper
• Anterior ischemic optic neuropathy comorbid with Factor V Leiden and PAI-1 4G/5G mutation.

  2009cites this paper
• Chapter 9 – Hemostatic Disorders Presenting as Cerebral Infarction

  2009cites this paper
• Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.

  2009cites this paper
• Nutrition and hemostasis: a focus on urbanization in South Africa.

  2008cites this paper
• Advances in the Genetic Basis of Ischemic Stroke

  2008cites this paper
• The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk.

  2008cites this paper
• Fibrinolysis: the key to new pathogenetic mechanisms.

  2008cites this paper
• Use of Intravenous Tissue Plasminogen Activator in a 16-Year-Old Patient with Basilar Occlusion

  2008cites this paper
• From THE DIVISION OF NEUROLOGY, DEPARTMENT OF CLINICAL NEUROSCIENCE Karolinska Institutet, Stockholm, Sweden GENETIC ANALYSIS OF ISCHEMIC STROKE

  2007cites this paper
• Genetic analysis of ischemic stroke and predisposing carotid artery stenosis : A stroke carol

  2007cites this paper
• Genetic association studies.

  2005cites this paper